Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 1/2016

15.06.2016 | REVIEW

Transforming the care of atrial fibrillation with mobile health

verfasst von: Mintu P. Turakhia, Daniel W. Kaiser

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Atrial fibrillation (AF) is a multifaceted and highly variable disease that is often difficult to manage within the traditional health-care model. The conventional model of regular or pre-scheduled appointments with physicians or allied health professionals is poorly suited to the unpredictable and often urgent clinical needs of patients with AF. Mobile health (mHealth) has the potential to dramatically transform the delivery and quality of AF care. In this brief review, we summarize the current limitations and evidence gaps in treating patients with AF. We then describe the current mHealth landscape, changes in telehealth coverage and reimbursement, and recent technological advances of smartphones, mobile applications, and connected wearable devices. We also describe important barriers and challenges, such as clinical management of large volumes of data, application of predictive analytics/machine learning, and the need for high-quality randomized clinical trials.
Literatur
1.
Zurück zum Zitat Turakhia MP, Hoang DD, Xu X, Frayne S, Schmitt S, Yang F, et al. Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: the Retrospective Evaluation and Assessment of Therapies in AF (TREAT-AF) study. Am Heart J. 2013;165(1):93–101. e101.CrossRefPubMed Turakhia MP, Hoang DD, Xu X, Frayne S, Schmitt S, Yang F, et al. Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: the Retrospective Evaluation and Assessment of Therapies in AF (TREAT-AF) study. Am Heart J. 2013;165(1):93–101. e101.CrossRefPubMed
2.
Zurück zum Zitat Shore S, Carey EP, Turakhia MP, Jackevicius CA, Cunningham F, Pilote L, et al. Adherence to dabigatran therapy and longitudinal patient outcomes: insights from the Veterans Health Administration. Am Heart J. 2014;167(6):810–7.CrossRefPubMed Shore S, Carey EP, Turakhia MP, Jackevicius CA, Cunningham F, Pilote L, et al. Adherence to dabigatran therapy and longitudinal patient outcomes: insights from the Veterans Health Administration. Am Heart J. 2014;167(6):810–7.CrossRefPubMed
3.
Zurück zum Zitat Shore S, Ho PM, Lambert-Kerzner A, Glorioso TJ, Carey EP, Cunningham F, et al. Site-level variation in and practices associated with dabigatran adherence. JAMA. 2015;313(14):1443–50.CrossRefPubMed Shore S, Ho PM, Lambert-Kerzner A, Glorioso TJ, Carey EP, Cunningham F, et al. Site-level variation in and practices associated with dabigatran adherence. JAMA. 2015;313(14):1443–50.CrossRefPubMed
4.
Zurück zum Zitat Turakhia MP, Ullal AJ. US health care policy and reform: implications for cardiac electrophysiology. J Interv Card Electrophysiol. 2013;36(2):129–36.CrossRefPubMed Turakhia MP, Ullal AJ. US health care policy and reform: implications for cardiac electrophysiology. J Interv Card Electrophysiol. 2013;36(2):129–36.CrossRefPubMed
8.
Zurück zum Zitat Chow CK, Redfern J, Hillis GS, Thakkar J, Santo K, Hackett ML, et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA. 2015;314(12):1255–63.CrossRefPubMed Chow CK, Redfern J, Hillis GS, Thakkar J, Santo K, Hackett ML, et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA. 2015;314(12):1255–63.CrossRefPubMed
11.
Zurück zum Zitat Mittal S, Movsowitz C, Steinberg JS. Ambulatory external electrocardiographic monitoring: focus on atrial fibrillation. J Am Coll Cardiol. 2011;58(17):1741–9.CrossRefPubMed Mittal S, Movsowitz C, Steinberg JS. Ambulatory external electrocardiographic monitoring: focus on atrial fibrillation. J Am Coll Cardiol. 2011;58(17):1741–9.CrossRefPubMed
12.
Zurück zum Zitat Turakhia MP, Hoang DD, Zimetbaum P, Miller JD, Froelicher VF, Kumar UN, et al. Diagnostic utility of a novel leadless arrhythmia monitoring device. Am J Cardiol. 2013;112(4):520–4.CrossRefPubMed Turakhia MP, Hoang DD, Zimetbaum P, Miller JD, Froelicher VF, Kumar UN, et al. Diagnostic utility of a novel leadless arrhythmia monitoring device. Am J Cardiol. 2013;112(4):520–4.CrossRefPubMed
13.
Zurück zum Zitat Barrett PM, Komatireddy R, Haaser S, Topol S, Sheard J, Encinas J, et al. Comparison of 24-hour Holter monitoring with 14-day novel adhesive patch electrocardiographic monitoring. Am J Med. 2014;127(1):95 e11–97.CrossRefPubMed Barrett PM, Komatireddy R, Haaser S, Topol S, Sheard J, Encinas J, et al. Comparison of 24-hour Holter monitoring with 14-day novel adhesive patch electrocardiographic monitoring. Am J Med. 2014;127(1):95 e11–97.CrossRefPubMed
16.
Zurück zum Zitat Turakhia MP, Shafrin J, Bognar K, Goldman DP, Mendys PM, Abdulsattar Y, et al. Economic burden of undiagnosed nonvalvular atrial fibrillation in the United States. Am J Cardiol. 2015;116(5):733–9.CrossRefPubMed Turakhia MP, Shafrin J, Bognar K, Goldman DP, Mendys PM, Abdulsattar Y, et al. Economic burden of undiagnosed nonvalvular atrial fibrillation in the United States. Am J Cardiol. 2015;116(5):733–9.CrossRefPubMed
17.
18.
Zurück zum Zitat Lowres N, Neubeck L, Salkeld G, Krass I, McLachlan AJ, Redfern J, et al. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study. Thromb Haemost. 2014;111(6):1167–76.CrossRefPubMed Lowres N, Neubeck L, Salkeld G, Krass I, McLachlan AJ, Redfern J, et al. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study. Thromb Haemost. 2014;111(6):1167–76.CrossRefPubMed
19.
Zurück zum Zitat Chyou, J. Y., Hunter, T. D., Mollenkopf, S. A., Turakhia, M. P., & Reynolds, M. R. (2015). Individual and combined risk factors for incident atrial fibrillation and incident stroke: an analysis of 3 million at-risk US patients. J Am Heart Assoc, 4(7), doi:10.1161/JAHA.114.001723. Chyou, J. Y., Hunter, T. D., Mollenkopf, S. A., Turakhia, M. P., & Reynolds, M. R. (2015). Individual and combined risk factors for incident atrial fibrillation and incident stroke: an analysis of 3 million at-risk US patients. J Am Heart Assoc, 4(7), doi:10.​1161/​JAHA.​114.​001723.
20.
Zurück zum Zitat Steven R. Steinhubl, M., Rajesh R. Mehta, R., Gail S. Ebner, B., Marissa M. Ballesteros, B., MBA, MPH, Waalena, J., Gregory Steinberg, M., BCh, et al. (2016). Rationale and design of a home-based trial using wearable sensors to detect asymptomatic atrial fibrillation in a targeted population: the mHealth screening to prevent strokes (mSToPS) trial. American Heart Journal. Steven R. Steinhubl, M., Rajesh R. Mehta, R., Gail S. Ebner, B., Marissa M. Ballesteros, B., MBA, MPH, Waalena, J., Gregory Steinberg, M., BCh, et al. (2016). Rationale and design of a home-based trial using wearable sensors to detect asymptomatic atrial fibrillation in a targeted population: the mHealth screening to prevent strokes (mSToPS) trial. American Heart Journal.
21.
Zurück zum Zitat Turakhia MP, Ullal AJ, Hoang DD, Than CT, Miller JD, Friday KJ, et al. Feasibility of extended ambulatory electrocardiogram monitoring to identify silent atrial fibrillation in high-risk patients: the Screening Study for Undiagnosed Atrial Fibrillation (STUDY-AF). Clin Cardiol. 2015;38(5):285–92.CrossRefPubMedPubMedCentral Turakhia MP, Ullal AJ, Hoang DD, Than CT, Miller JD, Friday KJ, et al. Feasibility of extended ambulatory electrocardiogram monitoring to identify silent atrial fibrillation in high-risk patients: the Screening Study for Undiagnosed Atrial Fibrillation (STUDY-AF). Clin Cardiol. 2015;38(5):285–92.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Passman, R., Leong-Sit, P., Andrei, A. C., Huskin, A., Tomson, T. T., Bernstein, R., et al. (2015). Targeted anticoagulation for atrial fibrillation guided by continuous rhythm assessment with an insertable cardiac monitor: the Rhythm Evaluation for Anticoagulation with Continuous Monitoring (REACT.COM) Pilot Study. J Cardiovasc Electrophysiol, doi:10.1111/jce.12864. Passman, R., Leong-Sit, P., Andrei, A. C., Huskin, A., Tomson, T. T., Bernstein, R., et al. (2015). Targeted anticoagulation for atrial fibrillation guided by continuous rhythm assessment with an insertable cardiac monitor: the Rhythm Evaluation for Anticoagulation with Continuous Monitoring (REACT.COM) Pilot Study. J Cardiovasc Electrophysiol, doi:10.​1111/​jce.​12864.
23.
Zurück zum Zitat Turakhia, M. P., & Estes, N. A., 3rd (2015). Stroke risk stratification in atrial fibrillation: bridging the evidence gaps. J Cardiovasc Electrophysiol, doi:10.1111/jce.12891. Turakhia, M. P., & Estes, N. A., 3rd (2015). Stroke risk stratification in atrial fibrillation: bridging the evidence gaps. J Cardiovasc Electrophysiol, doi:10.​1111/​jce.​12891.
24.
Zurück zum Zitat Keach JW, Bradley SM, Turakhia MP, Maddox TM. Early detection of occult atrial fibrillation and stroke prevention. Heart. 2015;101(14):1097–102.CrossRefPubMed Keach JW, Bradley SM, Turakhia MP, Maddox TM. Early detection of occult atrial fibrillation and stroke prevention. Heart. 2015;101(14):1097–102.CrossRefPubMed
25.
Zurück zum Zitat McManus DD, Lee J, Maitas O, Esa N, Pidikiti R, Carlucci A, et al. A novel application for the detection of an irregular pulse using an iPhone 4S in patients with atrial fibrillation. Heart Rhythm. 2013;10(3):315–9.CrossRefPubMed McManus DD, Lee J, Maitas O, Esa N, Pidikiti R, Carlucci A, et al. A novel application for the detection of an irregular pulse using an iPhone 4S in patients with atrial fibrillation. Heart Rhythm. 2013;10(3):315–9.CrossRefPubMed
26.
Zurück zum Zitat Ho PM, Lambert-Kerzner A, Carey EP, Fahdi IE, Bryson CL, Melnyk SD, et al. Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial. JAMA Intern Med. 2014;174(2):186–93.CrossRefPubMed Ho PM, Lambert-Kerzner A, Carey EP, Fahdi IE, Bryson CL, Melnyk SD, et al. Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial. JAMA Intern Med. 2014;174(2):186–93.CrossRefPubMed
27.
Zurück zum Zitat Patel N, Chung EH, Mounsey JP, Schwartz JD, Pursell I, Gehi AK. Effectiveness of atrial fibrillation monitor characteristics to predict severity of symptoms of atrial fibrillation. Am J Cardiol. 2014;113(10):1674–8.CrossRefPubMed Patel N, Chung EH, Mounsey JP, Schwartz JD, Pursell I, Gehi AK. Effectiveness of atrial fibrillation monitor characteristics to predict severity of symptoms of atrial fibrillation. Am J Cardiol. 2014;113(10):1674–8.CrossRefPubMed
29.
Zurück zum Zitat Hodge Jr JG, Weidenaar K, Baker-White A, Barraza L, Bauerly BC, Corbett A, et al. Legal innovations to advance a culture of health. J Law Med Ethics. 2015;43(4):904–12.PubMed Hodge Jr JG, Weidenaar K, Baker-White A, Barraza L, Bauerly BC, Corbett A, et al. Legal innovations to advance a culture of health. J Law Med Ethics. 2015;43(4):904–12.PubMed
31.
Zurück zum Zitat Basu S, Phillips RS, Bitton A, Song Z, Landon BE. Medicare chronic care management payments and financial returns to primary care practices: a modeling study. Ann Intern Med. 2015;163(8):580–8.CrossRefPubMed Basu S, Phillips RS, Bitton A, Song Z, Landon BE. Medicare chronic care management payments and financial returns to primary care practices: a modeling study. Ann Intern Med. 2015;163(8):580–8.CrossRefPubMed
Metadaten
Titel
Transforming the care of atrial fibrillation with mobile health
verfasst von
Mintu P. Turakhia
Daniel W. Kaiser
Publikationsdatum
15.06.2016
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 1/2016
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-016-0136-3

Weitere Artikel der Ausgabe 1/2016

Journal of Interventional Cardiac Electrophysiology 1/2016 Zur Ausgabe

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.